Tumor necrosis factor-alfa (TNF-a) antagonists are extensively utilized in the treatment of inflammatory rheumatic diseases such as rheumatoid arthritis (RA) and ankylosing spondylitis (AS). The gene discussed is TNF; the disease is rheumatoid arthritis.